Rare diseases
Investigational molecules
Locations
Eifflerstrasse 43, Altona-Altstadt, 22769 Hamburg, Germany
Immungenetics AG focuses on clinical research in newly diagnosed early-to-mild dementia due to Alzheimer’s disease, with interest in the transition from mild cognitive impairment to early dementia.
The sponsor’s trial activity centers on disease-related changes in the brain linked to amyloid-beta clearance and clinical assessment in the early symptomatic stages of Alzheimer’s disease.
Immungenetics AG runs clinical trials in conditions such as Dementia Alzheimer's type, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
